Harmonizing pharmaceutical product labeling (i.e., using identical labeling across multiple countries) can create time and cost efficiencies that benefit stakeholders across the value chain. Despite the clear benefits, there is little publicly available information for suppliers who want to pursue harmonized labeling for their products.
In this webinar, you will learn about recent efforts led by Impact RH360/Medicines360, WCG Cares, and FHI 360 to develop a strategy for harmonizing labeling for Impact RH360’s hormonal IUD product, Avibela. Insights from this assessment may be helpful for suppliers, regulatory experts, procurers, and others who seek to harmonize labeling for global health products.
Please note that the webinar will be recorded for those who wish to watch at a later date; please register for access to the recording.
Presenters:
Emily Morris, Associate Director, Regulatory Affairs, Impact RH360/Medicines360
Kelly Dannucci, Sr. Manager, Global Access, Impact RH360/Medicines360
Mark Busch, SVP, Quality Assurance & Product Safety, Impact RH360/Medicines360
Wilberto Robles, Sr. Director, Global Regulatory Affairs & Quality Assurance, WCG Cares
Moderator:
Kate Rademacher, Senior Technical Advisor, FHI 360
This event is hosted by the Reproductive Health Supplies Coalition (RHSC), the Hormonal IUD Access Group, and the Contraceptive Technology Innovation (CTI) Exchange.
For more information about global efforts to expand access to the hormonal IUD, visit: www.hormonaliud.org